Haluska G J, Cook M J, Novy M J
Oregon Regional Primate Research Center, Beaverton 97006, USA.
Am J Obstet Gynecol. 1997 Mar;176(3):682-91. doi: 10.1016/s0002-9378(97)70570-2.
Uterine quiescence during mammalian pregnancy is attributed to progesterone. However. systemic progesterone levels remain elevated in primates before parturition. Epostane, a selective 3beta-hydroxysteroid dehydrogenase inhibitor, and progesterone (with or without epostane) were administered to late pregnant rhesus monkeys to clarify the role of progesterone in primate parturition.
On days 122 to 132 of gestation (term 167 days), 11 rhesus monkeys (Macaca mulatta) with timed pregnancies were divided into three treatment groups: (1) epostane alone (10 mg/kg subcutaneously), (2) epostane with progesterone subcutaneously in Silastic silicone rubber capsules, and (3) progesterone implants only with no surgical instrumentation. Maternal and fetal blood and amniotic fluid were sampled for progesterone, estrone, estradiol, cortisol, testosterone, androstenedione, dehydroepiandrosterone, dehydroepiandrosterone sulfate, and amniotic fluid was sampled for prostaglandins E2 and F2alpha. Uterine activity was monitored continuously by electromyography and intraamniotic pressure. Cervical status was assessed by a modified Bishop's score. Production of prostaglandins E2 and F2alpha by amnion was determined by tissue superfusion. The group of three noninstrumented monkeys, which received only progesterone Silastic silicone rubber implants subcutaneously at 146 to 148 days, were observed until spontaneous vaginal delivery.
Epostane reduced maternal and fetal progesterone levels by 75% and 50%, respectively, followed by increased uterine activity and cervical ripening within 24 hours and vaginal delivery within 48 hours. Amniotic fluid progesterone decreased to undetectable levels. Progesterone implants prevented the epostane-induced decrease in maternal and fetal progesterone levels and the associated myometrial and cervical changes until the implants were removed. Alterations in other steroid hormones were consistent with inhibition of 3beta-hydroxysteroid dehydrogenase. Amniotic prostaglandin E2 production was increased sixfold by epostane (p < 0.05) but did not reach the high levels normally seen at spontaneous parturition. Animals that received progesterone implants alone had markedly elevated circulating progesterone concentrations yet were delivered spontaneously at term (range 163 to 167 days).
Progesterone withdrawal induces preterm labor and delivery (which can be blocked by progesterone substitution) but exogenous progesterone, even in substantial quantities, does not prevent parturition at term.
哺乳动物孕期子宫静止归因于孕酮。然而,灵长类动物在分娩前全身孕酮水平仍会升高。给予妊娠晚期恒河猴依泊斯坦(一种选择性3β - 羟基类固醇脱氢酶抑制剂)和孕酮(有或没有依泊斯坦),以阐明孕酮在灵长类动物分娩中的作用。
在妊娠第122至132天(足月为167天),将11只妊娠时间确定的恒河猴(猕猴)分为三个治疗组:(1)单独使用依泊斯坦(皮下注射10mg/kg),(2)依泊斯坦与皮下植入硅橡胶胶囊中的孕酮联合使用,(3)仅植入孕酮且无手术操作。采集母血、胎儿血和羊水样本检测孕酮、雌酮、雌二醇、皮质醇、睾酮、雄烯二酮、脱氢表雄酮、硫酸脱氢表雄酮,采集羊水样本检测前列腺素E2和F2α。通过肌电图和羊膜腔内压力连续监测子宫活动。通过改良的Bishop评分评估宫颈状态。通过组织灌流测定羊膜产生前列腺素E2和F2α的情况。对三只仅在146至148天皮下植入孕酮硅橡胶胶囊的未进行手术操作的猴子进行观察,直至自然阴道分娩。
依泊斯坦分别使母血和胎儿血中的孕酮水平降低75%和50%,随后在24小时内子宫活动增加、宫颈成熟,48小时内阴道分娩。羊水孕酮降至无法检测的水平。孕酮植入物可防止依泊斯坦引起的母血和胎儿血中孕酮水平下降以及相关的子宫肌层和宫颈变化,直至移除植入物。其他类固醇激素的变化与3β - 羟基类固醇脱氢酶的抑制作用一致。依泊斯坦使羊水中前列腺素E2的产生增加了六倍(p < 0.05),但未达到自然分娩时通常所见的高水平。仅接受孕酮植入物的动物循环孕酮浓度显著升高,但仍在足月时自然分娩(范围为163至167天)。
孕酮撤退会引发早产和分娩(可通过孕酮替代来阻断),但外源性孕酮即使大量使用也不能防止足月分娩。